Evaxion Financials - Benzinga

Evaxion AS

EVAXNASDAQ

Trade with Public

Trade with Public

$3.12

0.041.3%

At close: Sep 4, 5:00 PM EST

$3.12

-0.0026-0.08%

After Hours: Sep 4, 9:10 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Stock Report

Evaxion Financials

Evaxion (EVAX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Evaxion Biotech Q2 EPS $(0.01) Beats $(0.31) Estimate

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.31) by 96.77 percent. This is a 50 percent increase over losses of $(0.02) per share from the

Benzinga Newsdesk

PRO
Evaxion Biotech Q1 EPS $(0.01) Beats $(0.23) Estimate

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.23) by 95.65 percent. This is unchanged from the same period last year.

Benzinga Newsdesk

Evaxion Earnings Report: Q4 Overview

Benzinga Insights

PRO
Evaxion Biotech Q4 EPS $(0.02) Beats $(0.30) Estimate

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.30) by 93.27 percent. This is a 90.48 percent increase over losses of $(0.21) per share from

Benzinga Newsdesk

Insights into Evaxion Q4 Earnings

Benzinga Insights

Earnings Scheduled For March 5, 2026

Benzinga Insights